Latest news with #JohnLechleiter
Yahoo
22-05-2025
- Health
- Yahoo
Former Eli Lilly execs donate $20 million to establish IU Health clinical institute
Two former Eli Lilly executives and their families will donate $20 million to IU Health Foundation — the largest philanthropic gift in the foundation's history — to establish the Institute for Clinical Innovation, a hub for groundbreaking disease detection and treatment. IU Health will match the gift, bringing the total investment to $40 million shared between the health system and the medical school. The IU Health Foundation acts as the philanthropic arm of IU Health's statewide health care system. Housed in the massive IU hospital complex under construction on the north side of downtown, the institute will accelerate the speed of medical research in Indiana and provide clinicians and researchers with more resources. IU Health leaders say they hope the investment will triple the number of patients in clinical trials. They hope to enroll 75,000 patients in clinical trials each year and within five years enroll 300,000 people in the Indiana Biobank initiative. Indianapolis residents Sarah and John Lechleiter and Deborah and Randall Tobias partnered on the donation that will benefit patients across Indiana. Randall Tobias held the title of chair, president and CEO of Eli Lilly from 1993-2003, before he was nominated by President George W. Bush to lead the U.S. effort to fight against the global HIV/AIDS epidemic. John Lechleiter served as CEO of the pharmaceutical giant from 2008-2017 before handing over the reins to current CEO Dave Ricks. 'Our families share a commitment to advancing the future of healthcare for our Hoosier neighbors,' the Tobiases and Lechleiters said in a joint statement. 'This gift will support IU Health and IU School of Medicine in their joint efforts to expand clinical trial participation in our state for the benefit of patients in Indiana and around the globe.' 'The Lechleiter and Tobias families could have made this gift anywhere in the world. Choosing IU Health and IU School of Medicine demonstrates immense trust in our researchers and caregivers,' IU Health President and CEO Dennis Murphy said. 'Thanks to this commitment, our patients will get early access to life-saving treatments and The Institute for Clinical Innovation will become a destination for leading-edge healthcare.' IU Health's $2.31 billion hospital complex, which will replace the aging IU Health Methodist Hospital, is expected to open in late 2027. IU Health hospital development: 'If we only build a great hospital, we will have failed:' IU Health project spurs new group Alysa Guffey covers business and development for IndyStar. Contact her at amguffey@ This article originally appeared on Indianapolis Star: Former Lilly executives donate $20 million for IU clinical institute
Indianapolis Star
22-05-2025
- Health
- Indianapolis Star
Former Eli Lilly execs donate $20 million to establish IU Health clinical institute
Two former Eli Lilly executives and their families will donate $20 million to IU Health Foundation — the largest philanthropic gift in the foundation's history — to establish the Institute for Clinical Innovation, a hub for groundbreaking disease detection and treatment. IU Health will match the gift, bringing the total investment to $40 million shared between the health system and the medical school. The IU Health Foundation acts as the philanthropic arm of IU Health's statewide health care system. Housed in the massive IU hospital complex under construction on the north side of downtown, the institute will accelerate the speed of medical research in Indiana and provide clinicians and researchers with more resources. IU Health leaders say they hope the investment will triple the number of patients in clinical trials. They hope to enroll 75,000 patients in clinical trials each year and within five years enroll 300,000 people in the Indiana Biobank initiative. Indianapolis residents Sarah and John Lechleiter and Deborah and Randall Tobias partnered on the donation that will benefit patients across Indiana. Randall Tobias held the title of chair, president and CEO of Eli Lilly from 1993-2003, before he was nominated by President George W. Bush to lead the U.S. effort to fight against the global HIV/AIDS epidemic. John Lechleiter served as CEO of the pharmaceutical giant from 2008-2017 before handing over the reins to current CEO Dave Ricks. 'Our families share a commitment to advancing the future of healthcare for our Hoosier neighbors,' the Tobiases and Lechleiters said in a joint statement. 'This gift will support IU Health and IU School of Medicine in their joint efforts to expand clinical trial participation in our state for the benefit of patients in Indiana and around the globe.' 'The Lechleiter and Tobias families could have made this gift anywhere in the world. Choosing IU Health and IU School of Medicine demonstrates immense trust in our researchers and caregivers,' IU Health President and CEO Dennis Murphy said. 'Thanks to this commitment, our patients will get early access to life-saving treatments and The Institute for Clinical Innovation will become a destination for leading-edge healthcare.' IU Health's $2.31 billion hospital complex, which will replace the aging IU Health Methodist Hospital, is expected to open in late 2027.
